Published

The Therapeutic Potential of Psilocybin and 3,4-Methylenedioxymethamphetamine in the Treatment of Depression and Post-Traumatic Stress Disorder

An abstract is available from the original source but is not redistributed by this tracker. Read the source record.

Open source BibTeX RIS

Bibliographic context

Journal: Diva portal (Dalarna University Library)
Date: 2019-12-31
Source: OpenAlex
DOI: Unavailable
PubMed: Unavailable

Authors

Sofia Gyllvik

Watch author

Derived topics and classifications

psilocybin Depression Anxiety PTSD Mechanism of Action Clinical Trial Review Article Safety Clinical Trial

Citation graph

0 referenced DOIs found in stored source metadata. 0 indexed papers cite this DOI.

Open citation network

Related papers

Psilocybin-Assisted Therapy in Psychiatry: A Narrative Clinical Review of Mechanisms, Therapeutic Applications, and Emerging Evidence (2025-2026)Journal of Clinical Medicine · 2026-08-12 Psychedelic Therapies in the Management of Post-Traumatic Stress DisorderJournal of Education Health and Sport · 2026-07-16 Evaluating psilocybin for the management of depression: a literature reviewBritish Journal of Mental Health Nursing · 2026-08-02 Retreat from racism: A psychedelic group experience for racial stress and traumaPsychedelics · 2026-07-30 Psychedelic Therapy for DepressionUnknown journal · 2026-08-11 Beyond Monoamines: Ketamine, Esketamine, and Classic Psychedelics in the Treatment of DepressionZenodo (CERN European Organization for Nuclear Research) · 2026-07-17 Childhood trauma and psychological outcomes following psychedelic use: a scoping reviewnpj Mental Health Research · 2026-07-30 Psilocybin-containing mushroom-assisted psychotherapy is associated with sustained psychological and somatic improvements: two case studies from JamaicaFrontiers in Psychiatry · 2026-07-29